Beranda › Kanker Darah
Uji klinis Kanker Darah yang merekrut di AS
153 studi untuk Kanker Darah merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX46 studi
- New York City, NY26 studi
- Boston, MA25 studi
- Washington, DC19 studi
- Baltimore, MD18 studi
- Seattle, WA18 studi
- Los Angeles, CA17 studi
- Durham, NC16 studi
- Chicago, IL15 studi
- Philadelphia, PA14 studi
- Nashville, TN13 studi
- Atlanta, GA13 studi
- Edison, NJ13 studi
- Baldwin Park, CA13 studi
- Columbus, OH13 studi
- Milwaukee, WI12 studi
- Dallas, TX12 studi
- Detroit, MI12 studi
- Minneapolis, MN11 studi
- Birmingham, AL11 studi
- Ann Arbor, MI11 studi
- Omaha, NE10 studi
- Cincinnati, OH10 studi
- St. Louis, MO10 studi
- Jacksonville, FL10 studi
- Miami, FL9 studi
- Memphis, TN9 studi
- Cedar Rapids, IA9 studi
- Denver, CO9 studi
- San Antonio, TX8 studi
- Salt Lake City, UT8 studi
- Aurora, CO8 studi
- San Francisco, CA8 studi
- Clifton, NJ8 studi
- Tampa, FL8 studi
- Buffalo, NY7 studi
- Madison, WI7 studi
- Charlotte, NC7 studi
- Grand Rapids, MI7 studi
- Phoenix, AZ7 studi
Berdasarkan negara bagian
- Alabama11 studi
- Arizona12 studi
- Arkansas5 studi
- California35 studi
- Colorado14 studi
- Connecticut8 studi
- Delaware3 studi
- Distrik Columbia7 studi
- Florida28 studi
- Georgia16 studi
- Illinois16 studi
- Indiana9 studi
- Iowa9 studi
- Kansas7 studi
- Kentucky10 studi
- Louisiana6 studi
- Maryland29 studi
- Massachusetts26 studi
- Michigan22 studi
- Minnesota17 studi
- Missouri11 studi
- Nebraska10 studi
- Nevada4 studi
- New Hampshire3 studi
- New Jersey21 studi
- New York29 studi
- North Carolina24 studi
- Ohio22 studi
- Oklahoma8 studi
- Oregon8 studi
- Pennsylvania21 studi
- Rhode Island4 studi
- South Carolina8 studi
- South Dakota5 studi
- Tennessee20 studi
- Texas49 studi
- Utah8 studi
- Virginia11 studi
- Washington20 studi
- West Virginia5 studi
- Wisconsin15 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Menerima pesertaStudi observasional
Usia 18 hingga 110 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05724121Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06904066Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069Rutgers University Study of the Genetics of Blood Cancers
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 110 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07714044Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
Usia 0 hingga 38 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06131801A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06697184A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07572006A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04634552Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06910969Genomic Profiling in Cancer Patients
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT01775072Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06398457Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT04728893Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Menerima pesertaFase 3
Usia 18 hingga 71 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07504458Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345Wearable Activity Tracking to Curb Hospitalizations
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06587100Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
Menerima pesertaFase awal 1
Usia 12 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT04744116Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 12 hingga 120 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05470491Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07162038Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07648264Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07743476Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 12 hingga 120 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05327023Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04242095SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT05375643Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
Menerima pesertaFase 1
Hingga usia 75 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06345027Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.